HEADER TRANSFERASE/INHIBITOR 20-FEB-13 3ZO3 TITLE THE SYNTHESIS AND EVALUATION OF DIAZASPIROCYCLIC PROTEIN KINASE TITLE 2 INHIBITORS COMPND MOL_ID: 1; COMPND 2 MOLECULE: CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: PKA C-ALPHA; COMPND 5 EC: 2.7.11.11; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: CAMP-DEPENDENT PROTEIN KINASE INHIBITOR ALPHA; COMPND 9 CHAIN: I; COMPND 10 FRAGMENT: RESIDUES 6-23; COMPND 11 SYNONYM: PKI-ALPHA; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BOS TAURUS; SOURCE 3 ORGANISM_COMMON: BOVINE; SOURCE 4 ORGANISM_TAXID: 9913; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES; SOURCE 10 ORGANISM_SCIENTIFIC: BOS TAURUS; SOURCE 11 ORGANISM_COMMON: BOVINE; SOURCE 12 ORGANISM_TAXID: 9913 KEYWDS TRANSFERASE-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR C.E.ALLEN,C.L.CHOW,J.J.CALDWELL,I.M.WESTWOOD,R.L.VAN MONTFORT, AUTHOR 2 I.COLLINS REVDAT 6 20-DEC-23 3ZO3 1 REMARK LINK REVDAT 5 03-APR-19 3ZO3 1 REMARK LINK REVDAT 4 28-MAR-18 3ZO3 1 JRNL REVDAT 3 28-AUG-13 3ZO3 1 JRNL REVDAT 2 21-AUG-13 3ZO3 1 JRNL REVDAT 1 06-MAR-13 3ZO3 0 JRNL AUTH C.E.ALLEN,C.L.CHOW,J.J.CALDWELL,I.M.WESTWOOD, JRNL AUTH 2 R.L.VAN MONTFORT,I.COLLINS JRNL TITL SYNTHESIS AND EVALUATION OF HETEROARYL SUBSTITUTED JRNL TITL 2 DIAZASPIROCYCLES AS SCAFFOLDS TO PROBE THE ATP-BINDING SITE JRNL TITL 3 OF PROTEIN KINASES. JRNL REF BIOORG. MED. CHEM. V. 21 5707 2013 JRNL REFN ESSN 1464-3391 JRNL PMID 23920481 JRNL DOI 10.1016/J.BMC.2013.07.021 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.2 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 55.34 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 26748 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.176 REMARK 3 R VALUE (WORKING SET) : 0.175 REMARK 3 FREE R VALUE : 0.211 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.040 REMARK 3 FREE R VALUE TEST SET COUNT : 1347 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 13 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.19 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.81 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2975 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.1844 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2840 REMARK 3 BIN R VALUE (WORKING SET) : 0.1829 REMARK 3 BIN FREE R VALUE : 0.2147 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.54 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 135 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2865 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 58 REMARK 3 SOLVENT ATOMS : 279 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 34.04 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 35.08 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -7.97640 REMARK 3 B22 (A**2) : 6.07230 REMARK 3 B33 (A**2) : 1.90400 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.189 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.157 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.176 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.153 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.938 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.920 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 3005 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 4063 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1018 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 66 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 449 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 3005 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 374 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 3710 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.011 REMARK 3 BOND ANGLES (DEGREES) : 1.03 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.18 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 17.97 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: CHAIN A REMARK 3 ORIGIN FOR THE GROUP (A): -27.3338 -1.9361 2.6675 REMARK 3 T TENSOR REMARK 3 T11: -0.0969 T22: -0.0729 REMARK 3 T33: -0.1092 T12: 0.0106 REMARK 3 T13: 0.0030 T23: -0.0267 REMARK 3 L TENSOR REMARK 3 L11: 0.8650 L22: 1.4907 REMARK 3 L33: 1.6660 L12: 0.1580 REMARK 3 L13: -0.0232 L23: -0.5976 REMARK 3 S TENSOR REMARK 3 S11: -0.0034 S12: 0.0431 S13: 0.0451 REMARK 3 S21: -0.0601 S22: 0.0074 S23: 0.0933 REMARK 3 S31: -0.1300 S32: -0.1155 S33: -0.0040 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: CHAIN I REMARK 3 ORIGIN FOR THE GROUP (A): -14.0106 1.7522 -10.7209 REMARK 3 T TENSOR REMARK 3 T11: 0.0526 T22: 0.0222 REMARK 3 T33: -0.0744 T12: -0.0051 REMARK 3 T13: 0.0338 T23: -0.0125 REMARK 3 L TENSOR REMARK 3 L11: 1.4705 L22: 0.8386 REMARK 3 L33: 0.3902 L12: 0.1079 REMARK 3 L13: -0.4715 L23: -0.6355 REMARK 3 S TENSOR REMARK 3 S11: -0.0531 S12: 0.0522 S13: -0.0497 REMARK 3 S21: 0.0721 S22: -0.0464 S23: 0.0415 REMARK 3 S31: 0.0362 S32: 0.0250 S33: 0.0995 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: IDEAL-DIST CONTACT TERM CONTACT SETUP. REMARK 3 ALL ATOMS HAVE CCP4 ATOM TYPE FROM LIBRARY REMARK 4 REMARK 4 3ZO3 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 20-FEB-13. REMARK 100 THE DEPOSITION ID IS D_1290055878. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-AUG-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97630 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 26797 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 55.340 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.500 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 4.900 REMARK 200 R MERGE (I) : 0.12000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.16 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 4.90 REMARK 200 R MERGE FOR SHELL (I) : 0.47000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 2GFC REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.87 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.72 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 25MM MES-BISTRIS PH6.5, 75MM LICL, 1MM REMARK 280 DTT, 0.1MM EDTA, 1.5MM MEGA8; 4 DEGREE CELSIUS, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 36.41500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 40.25000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 38.10000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 40.25000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 36.41500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 38.10000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3960 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15630 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -11.2 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, I REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 0 REMARK 465 GLY A 1 REMARK 465 ASN A 2 REMARK 465 ALA A 3 REMARK 465 ALA A 4 REMARK 465 ALA A 5 REMARK 465 ALA A 6 REMARK 465 LYS A 7 REMARK 465 LYS A 8 REMARK 465 GLY A 9 REMARK 465 SER A 10 REMARK 465 HIS I 22A REMARK 465 ASP I 22B REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 11 CG CD OE1 OE2 REMARK 470 GLN A 12 CG CD OE1 NE2 REMARK 470 GLU A 13 CB CG CD OE1 OE2 REMARK 470 LYS A 16 CD CE NZ REMARK 470 GLU A 17 CD OE1 OE2 REMARK 470 LYS A 21 CG CD CE NZ REMARK 470 GLU A 24 CD OE1 OE2 REMARK 470 LYS A 28 CE NZ REMARK 470 LYS A 61 CE NZ REMARK 470 GLU A 64 CD OE1 OE2 REMARK 470 LYS A 83 CE NZ REMARK 470 LYS A 105 CE NZ REMARK 470 GLN A 176 CD OE1 NE2 REMARK 470 LYS A 213 CD CE NZ REMARK 470 LYS A 279 CE NZ REMARK 470 LYS A 285 CD CE NZ REMARK 470 ASN A 286 CG OD1 ND2 REMARK 470 LYS A 295 CD CE NZ REMARK 470 ILE A 303 CD1 REMARK 470 LYS A 309 CE NZ REMARK 470 GLU A 311 CG CD OE1 OE2 REMARK 470 LYS A 317 CD CE NZ REMARK 470 PHE A 318 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS A 319 CG CD CE NZ REMARK 470 GLU A 331 CG CD OE1 OE2 REMARK 470 GLU A 333 CD OE1 OE2 REMARK 470 GLU A 334 CG CD OE1 OE2 REMARK 470 ILE A 335 CD1 REMARK 470 LYS A 345 CD CE NZ REMARK 470 ILE I 22 CD1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 273 49.44 -93.78 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE QNI A 1351 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 1358 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 1359 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 1360 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 1361 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3ZO1 RELATED DB: PDB REMARK 900 THE SYNTHESIS AND EVALUATION OF DIAZASPIROCYCLIC PROTEIN KINASE REMARK 900 INHIBITORS REMARK 900 RELATED ID: 3ZO2 RELATED DB: PDB REMARK 900 THE SYNTHESIS AND EVALUATION OF DIAZASPIROCYCLIC PROTEIN KINASE REMARK 900 INHIBITORS REMARK 900 RELATED ID: 3ZO4 RELATED DB: PDB REMARK 900 THE SYNTHESIS AND EVALUATION OF DIAZASPIROCYCLIC PROTEIN KINASE REMARK 900 INHIBITORS DBREF 3ZO3 A 0 350 UNP P00517 KAPCA_BOVIN 1 351 DBREF 3ZO3 I 5 22 UNP Q3SX13 IPKA_BOVIN 6 23 SEQRES 1 A 351 MET GLY ASN ALA ALA ALA ALA LYS LYS GLY SER GLU GLN SEQRES 2 A 351 GLU SER VAL LYS GLU PHE LEU ALA LYS ALA LYS GLU ASP SEQRES 3 A 351 PHE LEU LYS LYS TRP GLU ASN PRO ALA GLN ASN THR ALA SEQRES 4 A 351 HIS LEU ASP GLN PHE GLU ARG ILE LYS THR LEU GLY THR SEQRES 5 A 351 GLY SER PHE GLY ARG VAL MET LEU VAL LYS HIS MET GLU SEQRES 6 A 351 THR GLY ASN HIS TYR ALA MET LYS ILE LEU ASP LYS GLN SEQRES 7 A 351 LYS VAL VAL LYS LEU LYS GLN ILE GLU HIS THR LEU ASN SEQRES 8 A 351 GLU LYS ARG ILE LEU GLN ALA VAL ASN PHE PRO PHE LEU SEQRES 9 A 351 VAL LYS LEU GLU PHE SER PHE LYS ASP ASN SER ASN LEU SEQRES 10 A 351 TYR MET VAL MET GLU TYR VAL PRO GLY GLY GLU MET PHE SEQRES 11 A 351 SER HIS LEU ARG ARG ILE GLY ARG PHE SEP GLU PRO HIS SEQRES 12 A 351 ALA ARG PHE TYR ALA ALA GLN ILE VAL LEU THR PHE GLU SEQRES 13 A 351 TYR LEU HIS SER LEU ASP LEU ILE TYR ARG ASP LEU LYS SEQRES 14 A 351 PRO GLU ASN LEU LEU ILE ASP GLN GLN GLY TYR ILE GLN SEQRES 15 A 351 VAL THR ASP PHE GLY PHE ALA LYS ARG VAL LYS GLY ARG SEQRES 16 A 351 THR TRP TPO LEU CYS GLY THR PRO GLU TYR LEU ALA PRO SEQRES 17 A 351 GLU ILE ILE LEU SER LYS GLY TYR ASN LYS ALA VAL ASP SEQRES 18 A 351 TRP TRP ALA LEU GLY VAL LEU ILE TYR GLU MET ALA ALA SEQRES 19 A 351 GLY TYR PRO PRO PHE PHE ALA ASP GLN PRO ILE GLN ILE SEQRES 20 A 351 TYR GLU LYS ILE VAL SER GLY LYS VAL ARG PHE PRO SER SEQRES 21 A 351 HIS PHE SER SER ASP LEU LYS ASP LEU LEU ARG ASN LEU SEQRES 22 A 351 LEU GLN VAL ASP LEU THR LYS ARG PHE GLY ASN LEU LYS SEQRES 23 A 351 ASN GLY VAL ASN ASP ILE LYS ASN HIS LYS TRP PHE ALA SEQRES 24 A 351 THR THR ASP TRP ILE ALA ILE TYR GLN ARG LYS VAL GLU SEQRES 25 A 351 ALA PRO PHE ILE PRO LYS PHE LYS GLY PRO GLY ASP THR SEQRES 26 A 351 SER ASN PHE ASP ASP TYR GLU GLU GLU GLU ILE ARG VAL SEQRES 27 A 351 SEP ILE ASN GLU LYS CYS GLY LYS GLU PHE SER GLU PHE SEQRES 1 I 20 THR THR TYR ALA ASP PHE ILE ALA SER GLY ARG THR GLY SEQRES 2 I 20 ARG ARG ASN ALA ILE HIS ASP MODRES 3ZO3 SEP A 139 SER PHOSPHOSERINE MODRES 3ZO3 TPO A 197 THR PHOSPHOTHREONINE MODRES 3ZO3 SEP A 338 SER PHOSPHOSERINE HET SEP A 139 10 HET TPO A 197 11 HET SEP A 338 10 HET QNI A1351 20 HET MOH A1352 2 HET MOH A1353 2 HET MOH A1354 2 HET MOH A1355 2 HET MOH A1356 2 HET MOH A1357 2 HET GOL A1358 6 HET GOL A1359 6 HET GOL A1360 6 HET GOL A1361 6 HET MOH A1362 2 HETNAM SEP PHOSPHOSERINE HETNAM TPO PHOSPHOTHREONINE HETNAM QNI 6-(2,9-DIAZASPIRO[5.5]UNDECAN-2-YL)-9H-PURINE HETNAM MOH METHANOL HETNAM GOL GLYCEROL HETSYN SEP PHOSPHONOSERINE HETSYN TPO PHOSPHONOTHREONINE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 1 SEP 2(C3 H8 N O6 P) FORMUL 1 TPO C4 H10 N O6 P FORMUL 3 QNI C14 H20 N6 FORMUL 4 MOH 7(C H4 O) FORMUL 10 GOL 4(C3 H8 O3) FORMUL 15 HOH *279(H2 O) HELIX 1 1 GLU A 11 ASN A 32 1 22 HELIX 2 2 HIS A 39 ASP A 41 5 3 HELIX 3 3 LYS A 76 LEU A 82 1 7 HELIX 4 4 GLN A 84 GLN A 96 1 13 HELIX 5 5 GLU A 127 GLY A 136 1 10 HELIX 6 6 SEP A 139 LEU A 160 1 22 HELIX 7 7 LYS A 168 GLU A 170 5 3 HELIX 8 8 THR A 201 LEU A 205 5 5 HELIX 9 9 ALA A 206 LEU A 211 1 6 HELIX 10 10 LYS A 217 GLY A 234 1 18 HELIX 11 11 GLN A 242 SER A 252 1 11 HELIX 12 12 SER A 262 LEU A 273 1 12 HELIX 13 13 VAL A 288 ASN A 293 1 6 HELIX 14 14 HIS A 294 ALA A 298 5 5 HELIX 15 15 ASP A 301 GLN A 307 1 7 HELIX 16 16 THR I 5 ALA I 12 1 8 SHEET 1 AA 5 PHE A 43 GLY A 52 0 SHEET 2 AA 5 GLY A 55 HIS A 62 -1 O GLY A 55 N GLY A 52 SHEET 3 AA 5 HIS A 68 ASP A 75 -1 O TYR A 69 N VAL A 60 SHEET 4 AA 5 ASN A 115 GLU A 121 -1 O LEU A 116 N LEU A 74 SHEET 5 AA 5 LEU A 106 LYS A 111 -1 N GLU A 107 O VAL A 119 SHEET 1 AB 2 LEU A 162 ILE A 163 0 SHEET 2 AB 2 LYS A 189 ARG A 190 -1 O LYS A 189 N ILE A 163 SHEET 1 AC 2 LEU A 172 ILE A 174 0 SHEET 2 AC 2 ILE A 180 VAL A 182 -1 O GLN A 181 N LEU A 173 LINK C PHE A 138 N SEP A 139 1555 1555 1.36 LINK C SEP A 139 N GLU A 140 1555 1555 1.33 LINK C TRP A 196 N TPO A 197 1555 1555 1.33 LINK C TPO A 197 N LEU A 198 1555 1555 1.33 LINK C VAL A 337 N SEP A 338 1555 1555 1.33 LINK C SEP A 338 N ILE A 339 1555 1555 1.34 SITE 1 AC1 15 LEU A 49 PHE A 54 VAL A 57 ALA A 70 SITE 2 AC1 15 GLU A 121 TYR A 122 VAL A 123 GLU A 127 SITE 3 AC1 15 GLU A 170 ASN A 171 LEU A 173 THR A 183 SITE 4 AC1 15 ASP A 184 PHE A 327 HOH A2167 SITE 1 AC2 3 HIS A 131 ASN A 326 HOH A2258 SITE 1 AC3 5 HIS A 39 ASP A 112 ASN A 113 HOH A2033 SITE 2 AC3 5 HOH A2036 SITE 1 AC4 3 VAL A 15 GLU A 155 HOH A2146 SITE 1 AC5 7 PHE A 18 ALA A 22 ASP A 25 ASN A 99 SITE 2 AC5 7 TYR A 156 HOH A2001 HOH A2095 CRYST1 72.830 76.200 80.500 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013731 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013123 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012422 0.00000